Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Drug Pricing Activity At US FDA May Be Unique To Gottlieb Tenure
Jan 30 2020
•
By
Derrick Gingery
The US FDA likely is not the primary agency for drug pricing work, a long-time stakeholder argued. • Source: Shutterstock
More from US FDA
More from Agency Leadership